The Importance of Natural (Inherited) and Acquired Immunity in Combating COVID-19.

Mohammed Marri Younus

doi:10.64516/wvzfye79

Authors

Mohammed Marri Younus Department of Zoology, Faculty of Art and Science, Derna of University, El-Gubba, Libya. Author

DOI:

https://doi.org/10.64516/wvzfye79

Keywords:

Acquired Immunity, Natural Immunity, Vaccines, Al Wahda Teaching Hospital, Umm Al Razm General Hospital, Gubba General Hospital.

Abstract

The current study included conducting a questionnaire regarding the comparison between natural and acquired immunity. It also indicates the importance of taking vaccines against the Covid-19 virus. The questionnaire was distributed to a sample size of 150 people from the medical and nursing staff in three Libyan hospitals including Al Wahda Teaching Hospital in Derna, Umm Al Razm General Hospital and Gubba General Hospital. The study performed during the period from 11/10/2020 to 11/10/2021. It has been shown that acquired immunity is the best in resisting the virus and recovering from it, and taking the vaccine in two doses is the best to make the body more immune. Also, the Chinese vaccines were the least types of vaccines in terms of side effects. Results found that the age group (1-10) years was having the most immune and considered the least in terms of death rate. While, the age group (66-98) was the most vulnerable age group to infection with the virus, and considered the most death rate groups.

References

1. Banks J, Karjalainen H, Propper C. (2020). Recessions and health: The longterm health consequences of responses to the coronavirus. Fisc Stud.;10(1111):1475–5890.

2. Bhopal SS, Bagaria J, Bayanne O, Bhopal R. (2021). Children and young people remain at low risk of COVID-19 mortality. Lancet. ;5(5):E12–3.

3. Castro A. (2020). Desafíos de la pandemia de COVID-19 en la salud de la mujer, de la niñez y de la adolescencia en América Latina y el Caribe. Nueva York: Programa de Naciones Unidas para el Desarrollo, Fondo de las Naciones Unidas para la Infancia. COVID-19 Ser Doc Política Pub. [Internet]; (PNUD LAC C19 PDS No.

4. Houghton C, Meskell P, Delaney H, Smalle M, Glenton C, Booth A, et al. (2020). Barriers and facilitators to healthcare workers' adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. The Cochrane database of systematic reviews.;4(4):CD013582.

5. Huang C, Wang Y, Li X, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet January 24, [Epub ahead of print].

6. Kam KQ, Yung CF, Cui L, et al. (2020). A well infant with coronavirus disease 2019 (COVID-19) with high viral load. Clin Infect Dis.

7. Parohan M, Yaghoubi S, Seraji A, Javanbakht MH, Sarraf P, Djalali M. (2020). Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. The Aging Male ;23(5):1416-1424. Disponible en:

8. Paules C, Marston H, Fauci A. (2020). Coronavirus infectionsemore than just the common cold. JAMA January 23, 2020 [Epub ahead of print].

9. Roberton T, Carter ED, Chou VB, Stegmuller AR, Jackson BD, Tam Y, et al. (2020). Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low- and middle-income countries: A modelling study. Lancet Glob Health.;8:e901-8.

10. Sadinsky S, Nuñez AJ, Nabulega S, Riley T, Ahmed Z, Sully E. (2020). From bad to worse: The COVID-19 pandemic risks further undermining adolescents’ sexual and reproductive health and rights in many countries [Internet]. New York: Guttmacher Inst; 2020 [acceso el 15 de abril del 2021]. Disponible en: https://www.guttmacher.org/ article/2020/08/bad-worse-covid-19-pandemic-risks-further-undermining-adolescents- sexual-and

11. Sagan A, Thomas S, McKee M, Karanikolos M, Figueras J. (2020). COVID-19 and health systems resilience: Lessons going forwards [Internet]. Eurohealth (London). 2020;26(2) [acceso el 15 de junio del 2021]. Disponible en: https://apps.who.int/iris/bitstream/ handle/10665/336290/Eurohealth-26-2-20-24- eng.pdf.

12. Stein F, Perry M, Banda G, Woolhouse M, Mutapi F. (2020). Oxygen provision to fight COVID-19 in sub-Saharan Africa. BMJ Global Health: 2020;5(6):e002786. Disponible en:

13. Yoshikawa H, Wuermli AJ, Britto PR, Dreyer B, Leckman JF, Lye SJ, et al. (2020). Effects of the global coronavirus disease-2019 pandemic on early childhood development: Short- and long-term risks and mitigating program and policy actions. J Pediatr.;223:188–93.

14. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet.;395(10229):1054-1062. Disponibleen: